global health
This article documents important examples of vaccine policies and diplomacy in Mexican history, some of them developed by new stakeholders as part of an emergent science diplomacy discourse.
This piece compiles the four presentations of the session on Global Health Diplomacy and Disaster Diplomacy, held virtually on the third day of the 2020 AAAS-TWAS Summer Course on Science Diplomacy on September 23, 2020.
The authors discuss the urgent necessity for the U.S. to address enduring systemic issues and develop strategies to integrate diplomacy into various dimensions of global health initiatives to significantly improve global health.
A reflection on the role of the Central European Initiative (CEI), the first intergovernmental forum for regional cooperation ever incepted in Europe, in responding to the COVID-19 crisis.
This article presents examples of Higher Education Institutions (HEIs)-based responses to the COVID-19 pandemic, demonstrating the importance of developing, supporting, and maintaining HEI networks in low- and middle-income countries.
I believe that science policy and science diplomacy can play a key part in getting America back on track, but that first requires a candid assessment of what has gone wrong with our science advisory ecosystem and science-policy-society interface.
In a crisis, turn to deliberate, collaborative, transparent science.
Catastrophic failures of the science-policy interface in many countries and globally have led to disastrous outcomes for public health, the economy, and international collaboration.
This is the story of PEPFAR's creation and early implementation from the perspective of the U.S. ambassador to Uganda, among the first countries in Africa to use data and evidence to describe, track, and treat HIV and AIDS patients.
In this article, the authors describe approaches to biosafety, biosecurity, and responsible conduct in the life sciences, including how they are covered by international treaties, international organizations, and professional organizations.
Connecting evidence to policy is a challenge worldwide but especially in Latin America, where resources are scarce and politics unpredictable.
Intranational and international multi-stakeholder engagement models hold the promise of reducing the global burden of cancer.